Syncing versus linking: A patient’s clinical trial journey
As precision medicines and highly individualized therapies become more common, patients are...
As precision medicines and highly individualized therapies become more common, patients are...
When our client, a global pharmaceutical company, set out to better understand long COVID pathways, they had a central question to answer:how much of the long COVID population are we missing if we rely on diagnosis codes alone?